Skip to main content
. 2012 Aug 22;7:4661–4677. doi: 10.2147/IJN.S34675

Figure 9.

Figure 9

Successfully established tumor xenograft model (A). The passive targeted in vivo tumor accumulation of fluorescein isothiocyanate delivered by polyethylenimine (PEI)- and vesicle-based polyplexes (B and C, respectively) under the same conditions.

Note: All the images were observed by the IVIS® Lumina II Imaging System (Caliper Life Sciences, Hopkinton, MA).

Abbreviation: ROI, region of interest.